Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EV71 Vaccine with MMR and Japanese Encephalitis Live Vaccine Co‑immunization Study
CTR20191006Phase 4Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Jun 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of enterovirus 71 vaccine (vero cell), inactivated in enterovirus 71 infection, measles, mumps, rubella, Japanese encephalitis (JE), sponsored by Sinovac Biotech Ltd.. Started Jun 2019; status: completed.
02
Drugs
enterovirus 71 vaccine (vero cell), inactivated
03
Conditions
enterovirus 71 infectionmeaslesmumpsrubellaJapanese encephalitis (JE)
Beyond the preview
Go deeper on CTR20191006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191006.